Download PDF
Rofo 2019; 191(04): 311-322
DOI: 10.1055/a-0690-9365
Review
© Georg Thieme Verlag KG Stuttgart · New York

Guideline-Oriented Therapy of Lower Extremity Peripheral Artery Disease (PAD) – Current Data and Perspectives

Article in several languages: English | deutsch
Jonas Kersting
1   Radiology, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany
,
Lars Kamper
1   Radiology, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany
,
Marco Das
2   Radiology, HELIOS Klinikum Duisburg, Germany
,
Patrick Haage
1   Radiology, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany
› Author Affiliations
Further Information

Publication History

22 March 2018

01 August 2018

Publication Date:
21 January 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Background Because of the demographic change, lower extremity peripheral artery disease (PAD) is becoming increasingly relevant with respect to health economics. PAD patients often suffer from multiple diseases. Consequently, therapy is commonly complex and requires an interdisciplinary approach. Because of rapid technical developments, interventional endovascular therapy regimens play an increasingly important role.

Method Review and literature search on the basis of the current German S3 guidelines on the therapy of PAD as well as international guidelines. In terms of state-of-the-art therapies, relevant current studies were considered.

Results Knowledge of existing guidelines and recommendations as well as new therapeutic approaches is essential for the adequate therapy of PAD patients. A close cooperation between the interventional radiologist and the vascular surgeon is the key to success. In addition to established conservative approaches and invasive bypass surgery, the endovascular approach has been a mainstay in the TASC A and B environment for years. It has recently shown promising results in advanced PAD conditions, such as TASC C and D. An endovascular-first strategy is defined in most guidelines.

Conclusion A primarily endovascular-first strategy has become the standard in the majority of even complex lesions of the lower extremity arterial system. Regarding the crural segment, a decrease in mortality compared to bypass surgery has been demonstrated. Further evidence can be expected from ongoing randomized multicenter trials.

Key Points: 

  • Adequate diagnostic examination is essential for the classification and strategy of therapy in PAD

  • Therapeutic decisions are ideally made in an interdisciplinary conference

  • Interventional therapy of intermittent claudication after exhaustion of conservative and medicamentous therapy

  • Endovascular-first approach in supra- and infrainguinal lesions

  • Additional evidence expected from future randomized trials

Citation Format

  • Kersting J, Kamper L, Das M et al. Guideline-Oriented Therapy of Lower Extremity Peripheral Artery Disease (PAD) – Current Data and Perspectives. Fortschr Röntgenstr 2019; 191: 311 – 322

Key words

aorta - blood vessels - vascular - angiography - angioplasty - arteriosclerosis
 

  • References

  • 1 Lawall H, Huppert P, Zemmrich CS. et al. S3-Leitlinie PAVK – Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. Vasa 2016; 45 (Suppl. 95) 1-100 . doi:10.1024/0301-1526/a000579
    PubMedSearch in Google Scholar
  • 2 Malyar N, Furstenberg T, Wellmann J. et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J 2013; 34: 2706-2714 . doi:eht288 [pii] 10.1093/eurheartj/eht288
    CrossrefPubMedSearch in Google Scholar
  • 3 Diehm C, Schuster A, Allenberg JR. et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105 . doi:S0021-9150(03)00204-1 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 4 Krause D, Burghaus I, Thiem U. et al. The risk of peripheral artery disease in older adults – seven-year results of the getABI study. Vasa 2016; 45: 403-410 . doi:10.1024/0301-1526/a000556
    CrossrefPubMedSearch in Google Scholar
  • 5 Collins R, Burch J, Cranny G. et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007; 334: 1257 . doi:bmj.39217.473275.55 [pii] 10.1136/bmj.39217.473275.55
    CrossrefPubMedSearch in Google Scholar
  • 6 McDonald JS, McDonald RJ, Lieske JC. et al. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure. Mayo Clin Proc 2015; 90: 1046-1053 . doi:S0025-6196(15)00468-1 [pii] 10.1016/j.mayocp.2015.05.016
    CrossrefPubMedSearch in Google Scholar
  • 7 Healy DA, Boyle EM, Clarke Moloney M. et al. Contrast-enhanced magnetic resonance angiography in diabetic patients with infra-genicular peripheral arterial disease: systematic review. Int J Surg 2013; 11: 228-232 . doi:S1743-9191(13)00032-0 [pii] 10.1016/j.ijsu.2013.02.001
    CrossrefPubMedSearch in Google Scholar
  • 8 Owen AR, Roditi GH. Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J 2011; 87: 189-198 . doi:pgmj.2009.082040 [pii] 10.1136/pgmj.2009.082040
    CrossrefPubMedSearch in Google Scholar
  • 9 Behrendt CA, Heidemann F, Haustein K. et al. Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers. Gefasschirurgie 2017; 22: 17-27 . doi:10.1007/s00772-016-0202-2202 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 10 Alahdab F, Wang AT, Elraiyah TA. et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg 2015; 61: 42S-53S . doi:S0741-5214(14)02283-6 [pii] 10.1016/j.jvs.2014.12.008
    PubMedSearch in Google Scholar
  • 11 Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med 2015; 45: 231-244 . doi:10.1007/s40279-014-0261-z
    CrossrefPubMedSearch in Google Scholar
  • 12 Jaff MR, White CJ, Hiatt WR. et al. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee. Ann Vasc Dis 2015; 8: 343-357 . doi:10.3400/avd.tasc.15-01000 avd.tasc.15-01000 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 13 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e726-e779 . doi:CIR.0000000000000471 [pii] 10.1161/CIR.0000000000000471
    PubMedSearch in Google Scholar
  • 14 Landgraf R. National practice guideline therapy of type 2 diabetes. MMW Fortschr Med 2014; 156 Spec No 1: 76-78
    PubMedSearch in Google Scholar
  • 15 Mills Sr JL, Conte MS, Armstrong DG. et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014; 59: 220-234 e221-e222 . doi:S0741-5214(13)01515-2 [pii] 10.1016/j.jvs.2013.08.003
    CrossrefPubMedSearch in Google Scholar
  • 16 Manzi M, Palena L, Cester G. Endovascular techniques for limb salvage in diabetics with crural and pedal disease. J Cardiovasc Surg (Torino) 2011; 52: 485-492 . doi:R37116843 [pii]
    PubMedSearch in Google Scholar
  • 17 Adam DJ, Beard JD, Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934 . doi:S0140-6736(05)67704-5 [pii] 10.1016/S0140-6736(05)67704-5
    CrossrefPubMedSearch in Google Scholar
  • 18 Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000; CD000990.
    PubMedSearch in Google Scholar
  • 19 Greenhalgh RM, Belch JJ, Brown LC. et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008; 36: 680-688 . doi:S1078-5884(08)00544-3 [pii] 10.1016/j.ejvs.2008.10.007
    CrossrefPubMedSearch in Google Scholar
  • 20 Momsen AH, Jensen MB, Norager CB. et al. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009; 38: 463-474 . doi:S1078-5884(09)00298-6 [pii] 10.1016/j.ejvs.2009.06.002
    CrossrefPubMedSearch in Google Scholar
  • 21 Indes JE, Pfaff MJ, Farrokhyar F. et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 2013; 20: 443-455 . doi:10.1583/13-4242.1
    CrossrefPubMedSearch in Google Scholar
  • 22 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med 2017; 22: NP1-NP43 . doi:10.1177/1358863X17701592
    CrossrefPubMedSearch in Google Scholar
  • 23 Grimme FA, Goverde PC, Verbruggen PJ. et al. Editorʼs Choice--First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease. Eur J Vasc Endovasc Surg 2015; 50: 638-647 . doi:S1078-5884(15)00540-7 [pii] 10.1016/j.ejvs.2015.06.112
    CrossrefPubMedSearch in Google Scholar
  • 24 Krankenberg H, Schluter M, Steinkamp HJ. et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292 . doi:CIRCULATIONAHA.107.689141 [pii] 10.1161/CIRCULATIONAHA.107.689141
    CrossrefPubMedSearch in Google Scholar
  • 25 Laird JR, Katzen BT, Scheinert D. et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012; 19: 1-9 . doi:10.1583/11-3627.1
    CrossrefPubMedSearch in Google Scholar
  • 26 Cassese S, Byrne RA, Ott I. et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 2012; 5: 582-589 . doi:CIRCINTERVENTIONS.112.969972 [pii] 10.1161/CIRCINTERVENTIONS.112.969972
    PubMedSearch in Google Scholar
  • 27 Dake MD, Ansel GM, Jaff MR. et al. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation 2016; 133: 1472-1483 ; discussion 1483. doi:CIRCULATIONAHA.115.016900 [pii] 10.1161/CIRCULATIONAHA.115.016900
    CrossrefPubMedSearch in Google Scholar
  • 28 De Cock E, Sapoval M, Julia P. et al. A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in France. Cardiovasc Intervent Radiol 2013; 36: 362-370 . doi:10.1007/s00270-012-0494-x
    CrossrefPubMedSearch in Google Scholar
  • 29 Katsanos K, Geisler BP, Garner AM. et al. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open 2016; 6: e011245 . doi:bmjopen-2016-011245 [pii] 10.1136/bmjopen-2016-011245
    CrossrefPubMedSearch in Google Scholar
  • 30 Zeller T, Langhoff R, Rocha-Singh KJ. et al. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study. Circ Cardiovasc Interv 2017; 10: e004848 . doi:CIRCINTERVENTIONS.116.004848 [pii] 10.1161/CIRCINTERVENTIONS.116.004848
    PubMedSearch in Google Scholar
  • 31 Baumhakel M, Chkhetia S, Kindermann M. Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry. Diagn Interv Radiol 2018; 24: 153-157 . doi:10.5152/dir.2018.17466
    PubMedSearch in Google Scholar
  • 32 Dominguez 3rd A, Bahadorani J. et al. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther 2015; 13: 429-444 . doi:10.1586/14779072.2015.1019472
    CrossrefPubMedSearch in Google Scholar
  • 33 Norgren L, Hiatt WR, Dormandy JA. et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26: 81-157
    PubMedSearch in Google Scholar
  • 34 Reinecke H, Unrath M, Freisinger E. et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 2015; 36: 932-938 . doi:ehv006 [pii] 10.1093/eurheartj/ehv006
    CrossrefPubMedSearch in Google Scholar
  • 35 Jongkind V, Akkersdijk GJ, Yeung KK. et al. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010; 52: 1376-1383 . doi:S0741-5214(10)01127-4 [pii] 10.1016/j.jvs.2010.04.080
    CrossrefPubMedSearch in Google Scholar
  • 36 Ye W, Liu CW, Ricco JB. et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011; 53: 1728-1737 . doi:S0741-5214(11)00298-9 [pii] 10.1016/j.jvs.2011.02.005
    CrossrefPubMedSearch in Google Scholar
  • 37 Suzuki K, Mizutani Y, Soga Y. et al. Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions. Angiology 2017; 68: 67-73 . doi:0003319716638005 [pii] 10.1177/0003319716638005
    CrossrefPubMedSearch in Google Scholar
  • 38 Bosiers M, Deloose K, Callaert J. et al. BRAVISSIMO: 12-month results from a large scale prospective trial. J Cardiovasc Surg (Torino) 2013; 54: 235-253 . doi:R37137462 [pii]
    PubMedSearch in Google Scholar
  • 39 Iida O, Soga Y, Takahara M. et al. Efficacy of the S.M.A.R.T. Control vs. other stents for aortoiliac occlusive disease in contemporary clinical practice. J Endovasc Ther 2013; 20: 431-439 . doi:10.1583/12-4156MR.1
    CrossrefPubMedSearch in Google Scholar
  • 40 Tewksbury R, Taumoepeau L, Cartmill A. et al. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions. Vascular 2015; 23: 630-636 . doi:1708538114568479 [pii] 10.1177/1708538114568479
    CrossrefPubMedSearch in Google Scholar
  • 41 Bradbury AW, Adam DJ, Bell J. et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51: 5S-17S . doi:S0741-5214(10)00233-8 [pii] 10.1016/j.jvs.2010.01.073
    CrossrefPubMedSearch in Google Scholar
  • 42 Zhang L, Bao J, Zhao Z. et al. Effectiveness of Viabahn in the Treatment of Superficial Femoral Artery Occlusive Disease: A Systematic Review and Meta-analysis. J Endovasc Ther 2015; 22: 495-505 . doi:1526602815588274 [pii] 10.1177/1526602815588274
    CrossrefPubMedSearch in Google Scholar
  • 43 McQuade K, Gable D, Pearl G. et al. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010; 52: 584-590 ; discussion 590–581, 591 e581–591 e587. doi:S0741-5214(10)00904-3 [pii] 10.1016/j.jvs.2010.03.071
    CrossrefPubMedSearch in Google Scholar
  • 44 Bosiers M, Peeters P, Tessarek J. et al. The Zilver(R) PTX(R) Single Arm Study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg (Torino) 2013; 54: 115-122 . doi:R37137272 [pii]
    PubMedSearch in Google Scholar
  • 45 Treitl M, Reiser MF, Treitl KM. Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates. Radiologe 2016; 56: 233-239 . doi:10.1007/s00117-016-0077-10.1007/s00117-016-0077-y [pii]
    CrossrefPubMedSearch in Google Scholar
  • 46 Zeller T, Baumgartner I, Scheinert D. et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 2014; 64: 1568-1576 . doi:S0735-1097(14)05714-3 [pii] 10.1016/j.jacc.2014.06.1198
    CrossrefPubMedSearch in Google Scholar
  • 47 Enezate TH, Omran J, Mahmud E. et al. Endovascular versus surgical treatment for acute limb ischemia: a systematic review and meta-analysis of clinical trials. Cardiovasc Diagn Ther 2017; 7: 264-271 . doi:10.21037/cdt.2017.03.03 cdt-07-03-264 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 48 Karnabatidis D, Spiliopoulos S, Tsetis D. et al. Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol 2011; 34: 1123-1136 . doi:10.1007/s00270-011-0258-z
    CrossrefPubMedSearch in Google Scholar